<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35529865</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Proteomic and Antibody Profiles Reveal Antigenic Composition and Signatures of Bacterial Ghost Vaccine of <i>Brucella abortus</i> A19.</ArticleTitle>
        <Pagination>
          <StartPage>874871</StartPage>
          <MedlinePgn>874871</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">874871</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.874871</ELocationID>
        <Abstract>
          <AbstractText>Brucellosis is an important zoonotic disease that causes great economic losses. Vaccine immunisation is the main strategy for the prevention and control of brucellosis. Although live attenuated vaccines play important roles in the prevention of this disease, they also have several limitations, such as residual virulence and difficulty in the differentiation of immunisation and infection. We developed and evaluated a new bacterial ghost vaccine of <i>Brucella abortus</i> A19 by a new double inactivation method. The results showed that the bacterial ghost vaccine of <i>Brucella</i> represents a more safe and efficient vaccine for brucellosis. We further characterised the antigenic components and signatures of the vaccine candidate A19BG. Here, we utilised a mass spectrometry-based label-free relative quantitative proteomics approach to investigate the global proteomics changes in A19BGs compared to its parental A19. The proteomic analysis identified 2014 proteins, 1116 of which were differentially expressed compared with those in A19. The common immunological proteins of OMPs (Bcsp31, Omp25, Omp10, Omp19, Omp28, and Omp2a), HSPs (DnaK, GroS, and GroL), and SodC were enriched in the proteome of A19BG. By protein micro array-based antibody profiling, significant differences were observed between A19BG and A19 immune response, and a number of signature immunogenic proteins were identified. Two of these proteins, the BMEII0032 and BMEI0892 proteins were significantly different (P &lt; 0.01) in distinguishing between A19 and A19BG immune sera and were identified as differential diagnostic antigens for the A19BG vaccine candidate. In conclusion, using comparative proteomics and antibody profiling, protein components and signature antigens were identified for the ghost vaccine candidate A19BG, which are valuable for further developing the vaccine and its monitoring assays.</AbstractText>
          <CopyrightInformation>Copyright © 2022 He, Yang, Ye, Zhao, Liu, Yang, Liu, He and Chen.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Chuan-Yu</ForeName>
            <Initials>CY</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Technology Center, Tecon Biological Co., Ltd., Urumqi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Jiang-Hua</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ye</LastName>
            <ForeName>Yin-Bo</ForeName>
            <Initials>YB</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Hai-Long</ForeName>
            <Initials>HL</Initials>
            <AffiliationInfo>
              <Affiliation>Technology Center, Tecon Biological Co., Ltd., Urumqi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Meng-Zhi</ForeName>
            <Initials>MZ</Initials>
            <AffiliationInfo>
              <Affiliation>Technology Center, Tecon Biological Co., Ltd., Urumqi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Qi-Lin</ForeName>
            <Initials>QL</Initials>
            <AffiliationInfo>
              <Affiliation>Technology Center, Tecon Biological Co., Ltd., Urumqi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Bao-Shan</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Sun</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Technology Center, Tecon Biological Co., Ltd., Urumqi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ze-Liang</ForeName>
            <Initials>ZL</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Technology Center, Tecon Biological Co., Ltd., Urumqi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Zoonose Prevention and Control at Universities of Inner Mongolia Autonomous Region, Innovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Key Laboratory of Tropical Diseases Control, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001428">Bacterial Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002004">Brucella Vaccine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001428" MajorTopicYN="N">Bacterial Vaccines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002004" MajorTopicYN="Y">Brucella Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002003" MajorTopicYN="N">Brucella abortus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002006" MajorTopicYN="Y">Brucellosis</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibody profile</Keyword>
        <Keyword MajorTopicYN="N">bacterial ghost</Keyword>
        <Keyword MajorTopicYN="N">brucellosis</Keyword>
        <Keyword MajorTopicYN="N">comparative proteomics</Keyword>
        <Keyword MajorTopicYN="N">vaccine</Keyword>
      </KeywordList>
      <CoiStatement>Authors C-YH, M-ZL, H-LZ, Q-LY, and SH are employed by Tecon Biological Co., Ltd. The remaining authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>4</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35529865</ArticleId>
        <ArticleId IdType="pmc">PMC9074784</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2022.874871</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Olsen SC, Palmer MV. Advancement of Knowledge of Brucella Over the Past 50 Years. Vet Pathol (2014) 51(6):1076–89. doi: 10.1177/0300985814540545
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0300985814540545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zheng R, Xie S, Lu X, Lu XB, Sun LH, Zhou Y, et al. . A Systematic Review and Meta-Analysis of Epidemiology and Clinical Manifestations of Human Brucellosis in China. BioMed Res Int (2018) 2018:5712920. doi: 10.1155/2018/5712920
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/5712920</ArticleId>
            <ArticleId IdType="pmc">PMC5937618</ArticleId>
            <ArticleId IdType="pubmed">29850535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Khurana SK, Sehrawat A, Tiwari R, Minakshi P, Baldev G, Muhammad Zubair  S, et al. . Bovine Brucellosis - a Comprehensive Review. Vet Q (2021) 41(1):61–88. doi: 10.1080/01652176.2020.1868616
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/01652176.2020.1868616</ArticleId>
            <ArticleId IdType="pmc">PMC7833053</ArticleId>
            <ArticleId IdType="pubmed">33353489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
González-Espinoza G, Arce-Gorvel V, Mémet S, Gorvel JP. 
Brucella: Reservoirs and Niches in Animals and Humans. Pathogens (2021) 10(2):186. doi: 10.3390/pathogens10020186
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pathogens10020186</ArticleId>
            <ArticleId IdType="pmc">PMC7915599</ArticleId>
            <ArticleId IdType="pubmed">33572264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang N, Huang D, Wu W, Liu J, Liang F, Zhou BS, et al. . Animal Brucellosis Control or Eradication Programs Worldwide: A Systematic Review of Experiences and Lessons Learned. Prev Vet Med (2018) 160:105–15. doi: 10.1016/j.prevetmed.2018.10.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.prevetmed.2018.10.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Avila-Calderón ED, Lopez-Merino A, Sriranganathan N, Boyle SM, Contreras-Rodríguez A. A History of the Development of Brucella Vaccines. BioMed Res Int (2013) 2013:743509. doi: 10.1155/2013/743509
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/743509</ArticleId>
            <ArticleId IdType="pmc">PMC3686056</ArticleId>
            <ArticleId IdType="pubmed">23862154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nayeri Fasaei B, Naserli S, Zahraei Salehi T, Saeedinia A, Behroozikhah A, Ashrafi Tamai I. New BrucellaS19 Mutant to Improve Distinction Between Infected and Vaccinated Animals. Iran J Biotechnol (2019) 17(3):e2159. doi: 10.29252/ijb.2159
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.29252/ijb.2159</ArticleId>
            <ArticleId IdType="pmc">PMC7080968</ArticleId>
            <ArticleId IdType="pubmed">32195284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Schurig GG, Roop RM, 2nd, Bagchi T, Boyle S, Buhrman D, Sriranganathan N, et al. . Biological Properties of RB51; a Stable Rough Strain of Brucella Abortus
. Vet Microbiol (1991) 28(2):171–88. doi: 10.1016/0378-1135(91)90091-S
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0378-1135(91)90091-S</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ponsart C, Riou M, Locatelli Y, Isabelle J, Alain F, Maryne J, et al. . 
Brucella Melitensis Rev.1 Vaccination Generates a Higher Shedding Risk of the Vaccine Strain in Alpine Ibex (Capra Ibex) Compared to the Domestic Goat (Capra Hircus). Vet Res (2019) 50(1):100. doi: 10.1186/s13567-019-0717-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13567-019-0717-0</ArticleId>
            <ArticleId IdType="pmc">PMC6882340</ArticleId>
            <ArticleId IdType="pubmed">31775863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Langemann T, Koller VJ, Muhammad A, Kudela P, Mayr UB, Lubitz W. The Bacterial Ghost Platform System: Production and Applications. Bioeng Bugs (2010) 1(5):326–36. doi: 10.4161/bbug.1.5.12540
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/bbug.1.5.12540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Batah AM, Ahmad TA. The Development of Ghost Vaccines Trials. Expert Rev Vaccines (2020) 19(6):549–62. doi: 10.1080/14760584.2020.1777862
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14760584.2020.1777862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kudela P, Koller VJ, Lubitz W. Bacterial Ghosts (BGs)–advanced Antigen and Drug Delivery System. Vaccine (2010) 28(36):5760–7. doi: 10.1016/j.vaccine.2010.06.087
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2010.06.087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu J, Li Y, Sun Y, Ji X, Zhu LW, Gao XJ, et al. . Immune Responses and Protection Induced by Brucella Suis S2 Bacterial Ghosts in Mice. Vet Immunol Immunopathol (2015) 166(3-4):138–44. doi: 10.1016/j.vetimm.2015.04.008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetimm.2015.04.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang SL, Li ZQ, Zhang JL, Li XI, Cui YY, Zhang WH, et al. . A Safe Non-Toxic Brucella Ghosts Induce Immune Responses and Confer Protection in BALB/c Mice. Mol Immunol (2020) 124:117–24. doi: 10.1016/j.molimm.2020.06.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molimm.2020.06.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
He CY, Yang JH, Zhao HL, Liu MZ, Wu DL, Liu BS, et al. . Vaccination With a Brucella Ghost Developed Through a Double Inactivation Strategy Provides Protection in Guinea Pigs and Cattle. Microb Pathog (2021) 162:105363. doi: 10.1016/j.micpath.2021.105363
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micpath.2021.105363</ArticleId>
            <ArticleId IdType="pubmed">34919994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen JS, Li N, She FF.  Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice. Vaccine (2014) 32(46):6054–60. doi: 10.1016/j.vaccine.2014.09.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.09.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Witte A, Wanner G, Sulzner M, Lubitz W. Dynamics of PhiX174 Protein E-Mediated Lysis of Escherichia Coli. Arch Microbiol (1992) 157(4):381–8. doi: 10.1007/BF00248685
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00248685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yang JH, He CY, Zhang H, Liu MZ, Zhao HL, Ren  LS, et al. . Evaluation and Differential Diagnosis of a Genetic Marked Brucella Vaccine A19Δvirb12 for Cattle. Front Immunol (2021) 12. doi: 10.3389/fimmu.2021.679560
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2021.679560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Blake JA, Christie KR, Dolan ME, Drabkin HJ, Hill DP, Ni L, et al. . Gene Ontology Consortium: Going Forward. Nucleic Acids Res (2015) 43:1049–56. doi: 10.1093/nar/gku1179
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gku1179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Minoru K, Miho F, Mao T, Yoko S, Kanae M. KEGG: New Perspectives on Genomes, Pathways, Diseases and Drugs. Nucleic Acids Res (2017) 45(D1):353–61. doi: 10.1093/nar/gkw1092
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkw1092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Galperin MY, Makarova KS, Wolf YI, et al. . Expanded Microbial Genome Coverage and Improved Protein Family Annotation in the COG Database. Nucleic Acids Res (2015) 43:261–9. doi: 10.1093/nar/gku1223
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gku1223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goodwin ZI, Pascual DW. Brucellosis Vaccines for Livestock. Vet Immunol Immunopathol (2016) 181:51–8. doi: 10.1016/j.vetimm.2016.03.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetimm.2016.03.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Minhas P, Kumar B, Verma R. Expression of Recombinant DnaK of Brucella Abortus and Its Evaluation as Immuno-Modulator. Arch Microbiol (2021) 203(5):2719–25. doi: 10.1007/s00203-021-02190-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00203-021-02190-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abbassi-Daloii T, Yousefi S, Sekhavati MH, Mojtaba T. Impact of Heat Shock Protein 60KD in Combination With Outer Membrane Proteins on Immune Response Against Brucella Melitensis. Apmis (2018) 126(1):65–75. doi: 10.1111/apm.12778
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apm.12778</ArticleId>
            <ArticleId IdType="pubmed">29154438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang S, Wang W, Sun K, Bateer HH, Zhao XL. Comparative Genomic Analysis Between Newly Sequenced Brucella Abortus Vaccine Strain A19 and Another Brucella Abortus Vaccine S19. Genomics (2019) 112(2):1444–53. doi: 10.1016/j.ygeno.2019.08.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ygeno.2019.08.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Crasta OR, Folkerts O, Fei Z, Shrinivasrao PM, Clive E, Susan MC, et al. . Genome Sequence of Brucella Abortus Vaccine Strain S19 Compared to Virulent Strains Yields Candidate Virulence Genes. PloS One (2008) 3(5):e2193. doi: 10.1371/journal.pone.0002193
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0002193</ArticleId>
            <ArticleId IdType="pmc">PMC2364660</ArticleId>
            <ArticleId IdType="pubmed">18478107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cheng Z, Li Z, Yin Y, Lian ZM, Hosny AA, Hu H, et al. . Characteristics of Brucella Vaccine Strain A19 Reveals Its Potential Mechanism of Attenuated Virulence. Vet Microbiol (2021) 254:109007. doi: 10.1016/j.vetmic.2021.109007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2021.109007</ArticleId>
            <ArticleId IdType="pubmed">33582483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Walcher P, Mayr UB, Azimpour-Tabrizi C, Francis OE, Wolfgang J, Peter M, et al. . Antigen Discovery and Delivery of Subunit Vaccines by Nonliving Bacterial Ghost Vectors. Expert Rev Vaccines (2004) 3(6):681–91. doi: 10.1586/14760584.3.6.681
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14760584.3.6.681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fu X, Himes BA, Ke D, Rice WJ, Ning J, Zhang P. Controlled Bacterial Lysis for Electron Tomography of Native Cell Membranes. Structure (2014) 22(12):1875–82. doi: 10.1016/j.str.2014.09.017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.str.2014.09.017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Breijyeh Z, Jubeh B, Karaman R. Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules (2020) 25(6):1340. doi: 10.3390/molecules25061340
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25061340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hensel A, Huter V, Katinger A, Raza P, Strnistschie C, Roesler U, et al. . Intramuscular Immunisation With Genetically Inactivated (Ghosts) Actinobacillus Pleuropneumoniae Serotype 9 Protects Pigs Against Homologous Aerosol Challenge and Prevents Carrier State. Vaccine (2000) 18(26):2945–55. doi: 10.1016/S0264-410X(00)00107-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0264-410X(00)00107-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Marchart J, Dropmann G, Lechleitner S, Schlapp T, Wanner G, Szostak MP, et al. . Pasteurella Multocida- and Pasteurella Haemolytica-Ghosts: New Vaccine Candidates. Vaccine (2003) 21(25-26):3988–97. doi: 10.1016/S0264-410X(03)00383-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0264-410X(03)00383-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mayr UB, Haller C, Haidinger W, Atrasheuskaya A, Bukin E, Lubitz W, et al. . Bacterial Ghosts as an Oral Vaccine: A Single Dose of Escherichia Coli O157:H7 Bacterial Ghosts Protects Mice Against Lethal Challenge. Infect Immun (2005) 73(8):4810–7. doi: 10.1128/IAI.73.8.4810-4817.2005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.73.8.4810-4817.2005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jawale CV, Lee JH. Comparative Evaluation of Salmonella Enteritidis Ghost Vaccines With a Commercial Vaccine for Protection Against Internal Egg Contamination With Salmonella. Vaccine (2014) 32(45):5925–30. doi: 10.1016/j.vaccine.2014.08.072
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.08.072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jawale CV, Lee JH. Characterisation of a Salmonella Typhimurium Ghost Carrying an Adjuvant Protein as a Vaccine Candidate for the Protection of Chickens Against Virulent Challenge. Avian Pathol (2014) 43(6):506–13. doi: 10.1080/03079457.2014.966303
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/03079457.2014.966303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Poetsch A, Marchesini MI. Proteomics of Brucella. Proteomes (2020) 8(2):8. doi: 10.3390/proteomes8020008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/proteomes8020008</ArticleId>
            <ArticleId IdType="pmc">PMC7355872</ArticleId>
            <ArticleId IdType="pubmed">32331335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhao Z, Yan F, Ji W, Luo DY, Liu X, Xing L, et al. . Identification of Immunoreactive Proteins of Brucella Melitensis by Immunoproteomics. Sci China Life Sci (2011) 54(9):880–7. doi: 10.1007/s11427-011-4218-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11427-011-4218-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cassataro J, Velikovsky CA, de la Barrera S, Estein SM, Bruno L, Bowden R, et al. . A DNA Vaccine Coding for the Brucella Outer Membrane Protein 31 Confers Protection Against B. Melitensis and B. Ovis Infection by Eliciting a Specific Cytotoxic Response. Infect Immun (2005) 73(10):6537–46. doi: 10.1128/IAI.73.10.6537-6546.2005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.73.10.6537-6546.2005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Luo D, Ni B, Li P, Shi W, Zhang S, Han Y, et al. . Protective Immunity Elicited by a Divalent DNA Vaccine Encoding Both the L7/L12 and Omp16 Genes of Brucellain BALB/c Mice. Infect Immun (2006) 74(5):2734–41. doi: 10.1128/IAI.74.5.2734-2741.2006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.74.5.2734-2741.2006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goel D, Rajendran V, Ghosh PC, Bhatnagar R. Cell Mediated Immune Response After Challenge in Omp25 Liposome Immunised Mice Contributes to Protection Against Virulent Brucella 544. Vaccine (2013) 31(8):1231–7. doi: 10.1016/j.vaccine.2012.12.043
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2012.12.043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ko J, Splitter GA. Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and Humans. Clin Microbiol Rev (2003) 16(1):65–78. doi: 10.1128/CMR.16.1.65-78.2003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.16.1.65-78.2003</ArticleId>
            <ArticleId IdType="pmc">PMC145300</ArticleId>
            <ArticleId IdType="pubmed">12525425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
González-Smith A, Vemulapalli R, Andrews E, Oñate A. Evaluation of Brucella DNA Vaccine by Expression of Cu-Zn Superoxide Dismutase Antigen Fused to IL-2. Immunobiology (2006) 211(1-2):65–74. doi: 10.1016/j.imbio.2005.09.004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.imbio.2005.09.004</ArticleId>
            <ArticleId IdType="pubmed">16446171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Arsène F, Tomoyasu T, Bukau B. The Heat Shock Response of Escherichia Coli. Int J Food Microbiol (2000) 55(1-3):3–9. doi: 10.1016/S0168-1605(00)00206-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-1605(00)00206-3</ArticleId>
            <ArticleId IdType="pubmed">10791710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim JY, Sung SR, Lee K, Lee HK, Kang SI, Lee JJ, et al. . Immunoproteomics of Brucella RB51 as Candidate Antigens in Serological Diagnosis of Brucellosis. Vet Immunol Immunopathol (2014) 160(3-4):218–24. doi: 10.1016/j.vetimm.2014.05.009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetimm.2014.05.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Minhas P, Kumar B, Verma R. Expression of Recombinant DnaK of Brucella and Its Evaluation as Immuno-Modulator. Arch Microbiol (2021) 203(5):2719–25. doi: 10.1007/s00203-021-02190-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00203-021-02190-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Connolly JP, Comerci D, Alefantis TG, Timothy G, Alefantis, Alexander WE, et al. . Proteomic Analysis of Brucellacell Envelope and Identification of Immunogenic Candidate Proteins for Vaccine Development. Proteomics (2006) 6(13):3767–80. doi: 10.1002/pmic.200500730
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pmic.200500730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Im YB, Park WB, Jung M, Kim S, Yoo HS. Comparative Analysis of Immune Responses to Outer Membrane Antigens OMP10, OMP19, and OMP28 of Brucella Abortus. Jpn J Infect Dis (2018) 71(3):197–204. doi: 10.7883/yoken.JJID.2017.019
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7883/yoken.JJID.2017.019</ArticleId>
            <ArticleId IdType="pubmed">29709972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mayfield JE, Bricker BJ, Godfrey H, Crosby RM, Knight DJ, Hailing SM, et al. . The Cloning, Expression, and Nucleotide Sequence of a Gene Coding for an Immunogenic Brucella Protein. Gene (1988) 63(1):1–9. doi: 10.1016/0378-1119(88)90540-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0378-1119(88)90540-9</ArticleId>
            <ArticleId IdType="pubmed">3133283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goel D, Bhatnagar R. Intradermal Immunisation With Outer Membrane Protein 25 Protects Balb/c Mice From Virulent B. Abortus 544. Mol Immunol (2012) 51(2):159–68. doi: 10.1016/j.molimm.2012.02.126
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molimm.2012.02.126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, et al. . Immunisation With Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection Against Brucella Infection. Infect Immun (2009) 77(1):436–45. doi: 10.1128/IAI.01151-08
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01151-08</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Huynh TH, Lauren TA, Tran XNH, Alisha WBR, WonGi M, Hu JL, et al. . Immunisation With a Combination of Four Recombinant Brucella Proteins Omp16, Omp19, Omp28, and L7/L12 Induces T Helper 1 Immune Response Against Virulent B. Abortus 544 Infection in BALB/c Mice. Front Vet Sci (2020) 7:577026. doi: 10.3389/fvets.2020.577026
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fvets.2020.577026</ArticleId>
            <ArticleId IdType="pmc">PMC7854899</ArticleId>
            <ArticleId IdType="pubmed">33553273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yu DH, Hu XD, Cai H. A Combined DNA Vaccine Encoding BCSP31, SOD, and L7/L12 Confers High Protection Against Brucella 2308 by Inducing Specific CTL Responses. DNA Cell Biol (2007) 26(6):435–43. doi: 10.1089/dna.2006.0552
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/dna.2006.0552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Muñoz PM, Marín CM, Monreal D, González D, GarinBastuji B, Díaz R, et al. . Efficacy of Several Serological Tests and Antigens for Diagnosis of Bovine Brucellosis in the Presence of False-Positive Serological Results Due to Yersinia Enterocolitica O:9. Clin Diagn Lab Immunol (2005) 12(1):141–51. doi: 10.1128/CDLI.12.1.141-151.2005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CDLI.12.1.141-151.2005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Al Dahouk S, Nöckler K, Scholz HC, Tomaso H, Bogumil R, Neubauer H. Immunoproteomic Characterisation of Brucella Abortus 1119-3 Preparations Used for the Serodiagnosis of
Brucella Infections. J Immunol Methods (2006) 309(1-2):34–47. doi: 10.1016/j.jim.2005.11.003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jim.2005.11.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Caroff M, Bundle DR, Perry MB. Structure of the O-Chain of the Phenol-Phase Soluble Cellular Lipopolysaccharide of Yersinia Enterocolitica Serotype O:9. Eur J Biochem (1984) 139(1):195–200. doi: 10.1111/j.1432-1033.1984.tb07994.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1432-1033.1984.tb07994.x</ArticleId>
            <ArticleId IdType="pubmed">6199199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Caroff M, Bundle DR, Perry MB, Cherwonogrodzky JW, Duncan JR. Antigenic S-Type Lipopolysaccharide of Brucella Abortus 1119-3. Infect Immun (1984) 46(2):384–8. doi: 10.1128/iai.46.2.384-388.1984
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.46.2.384-388.1984</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
